Search results for: “hpv”

  • Researchers Examine Vaccine Confidence and Hesitancy in Healthcare Settings in Northern BC

    Through an online survey, researchers conducted a survey to better understand vaccine confidence and vaccine hesitancy in individuals working in healthcare settings in Northern BC. In this guest blog post, learn what they discovered.

  • Reflections: A Fundraising ‘Year’ in Review

    Reflections from Colt Long, Development & Communications Manager on what the past year of fundraising has looked like for the Foundation.

  • HPV Vaccine Program Evaluation

    Project Duration: April 1, 2009 to September 30, 2011 This study was conducted to determine the baseline (i.e. pre-vaccine) HPV type specific prevalence in a population-based sample of women presenting for routine cervical cancer screening. From June 2010 to December 2010, a total of 2,100 physicians from all health regions in the province were invited…

  • QUEST – Quadrivalent HPV Vaccine Evaluation Study

    Project Duration: August 31, 2012 to August 30, 2013 This program is part of a national initiative (QUEST) to compare the durability and efficacy of 2 different vaccination programs against HPV in girls ages 9-12. Participants are enrolled across Canada. Vaccine is given as either 2-doses or 3-doses as part of a larger clinical trial.…

  • Evaluation of HPV Interventions in BC

    Project Duration: June 1, 2013 to April 30, 2017 Vaccine treatment is highly effective in preventing Human Papilloma Virus (HPV) infections in women, but there is controversy over the right age at which to start a vaccination program in girls. This project examines the acceptability of a vaccination program for grade 6 girls. It will…

  • ASPIRE

    Project Duration: November 1, 2013 to March 31, 2016 The ASPIRE (Advances in Screening and Prevention in Reproductive Cancer) program is a community-driven initiative in Uganda, designed to evaluate the acceptability and needs of a self-collection cervical cancer screening program for Human Papilloma Virus (HPV). The study will screen 300 women in an impoverished community.…